Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 23, 2020
Vaccinex has entered into a collaboration agreement with Merck through a subsidiary, to evaluate the combination of Vaccinex’s investigational SEMA4D inhibitor, pepinemab and KEYTRUDA for advanced, recurrent or metastatic head and neck squamous cell ...
read more
Thursday, November 30, 2017
Catalent and Vaccinex will develop an ADC using Catalent’s SMARTag conjugation platform and GPEx cell line engineering technologies, and Vaccinex’s ActivMAb technology.
read more
Wednesday, February 24, 2021
Vaccinex announced Surface Oncology will be exercising its option to license the anti-CCR8 antibody discovered via Vaccinex’s ActivMAb antibody discovery and novel viral display platform.
read more
A vaccine offering new hope for millions of Alzheimer’s disease patients, their physicians and caregivers has passed a Phase 1 safety trial.
read more
United Cargo approves carriage of the va-Q-tainer container line to meet increasing customer demands for robust passive pallet shippers.
read more
Friday, November 13, 2020
WCG announced the VA is implementing WCG's IRBNet electronic submission and review system for more than 100 VA medical centers that have research programs.
read more
SALT LAKE CITY (AP) — Utah state attorneys have asked an appeals court to clear the way for a contentious law that bans price fixing by contact lens makers and could have wide-ranging implications for the $4 billion industry
read more
Wednesday, April 16, 2014
Hovione announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for a capsule-based, low-cost dry powder inhaler (DPI) to Hovione. This happened less than three years after the patent was filed and after just ...
read more
USP is providing free technical assistance to developers of medical treatments such as antiviral drugs and vaccines that can support the public health response to the COVID-19 pandemic.
read more
USP is offering an online toolkit with guidelines from major public health organizations on compounding alcohol-based hand sanitizers and the preparation of hand sanitizers.
read more
Wednesday, September 09, 2015
The United States Pharmacopeial Convention (USP) has announced that Anthony (Tony) Lakavage, J.D., will become Senior Vice President, Global External Affairs, beginning on September 14.
read more
U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide.
read more
Monday, December 12, 2022
The U.S. Pharmacopeia (USP) announced the opening of the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its launch of a suite of R&D analytical solutions.
read more
Tuesday, February 19, 2019
USP has announced an upcoming workshop in Maryland to address the challenges faced by industry, regulators, and other stakeholders regarding endotoxin and pyrogen testing.
read more
When a core tablet proved too weak to withstand coating, scientists at Metrics Inc. made it stronger.
While that sounds simple enough, Metrics’ scientists tackled the problem using Quality By Design, which has been embraced by the International ...
read more